Chargement en cours...
Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?
Idiopathic pulmonary fibrosis is a rare, life threatening disease characterized by an anarchic fibrogenesis, limited survival and few therapeutic options. Its pathogenesis is complex and involves the interaction among various pathways driven by proinflammatory/profibrogenetic mediators such as plate...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3541099/ https://ncbi.nlm.nih.gov/pubmed/23146151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2049-6958-7-41 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|